2009
DOI: 10.1016/j.gene.2009.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 26 publications
0
8
0
Order By: Relevance
“…Patient cells showed approximately 1.5 times the level of ROS after DNA damage in comparison to control cells whilst in null mutant mouse cells the levels were more than two fold increased. We have previously described individual variations in the level of p70-nibrin expression [16] which are due to differences in its proteasomal degradation [49]. Low levels of p70-nibrin correlate with cancer incidence and it can be speculated that a contributing factor may be higher oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
“…Patient cells showed approximately 1.5 times the level of ROS after DNA damage in comparison to control cells whilst in null mutant mouse cells the levels were more than two fold increased. We have previously described individual variations in the level of p70-nibrin expression [16] which are due to differences in its proteasomal degradation [49]. Low levels of p70-nibrin correlate with cancer incidence and it can be speculated that a contributing factor may be higher oxidative stress.…”
Section: Discussionmentioning
confidence: 99%
“…14,15 Although genotyping common founder mutations in NBS is a useful diagnostic approach, the detection of elevated ␣-fetoprotein serum levels or truncations of the ATM protein is more practicable in AT. [16][17][18] The therapeutic perspective for AT and NBS patients has made considerable progress during recent years, providing evidence for successful stem cell transplantation in NBS and slowdown of neurodegeneration in AT using antioxidants and poly(ADPribose) polymerase inhibitors. 19,20 Novel treatment strategies also might arise from the use of translational read-through compounds to correct the ATM gene function, whereas the substitution of immunoglobulin preparations is commonplace practice to treat the humoral immunodeficiency in NBS and to improve the clinical outcome.…”
Section: Diagnostic Procedures For Routine Prospective Guthrie Card Amentioning
confidence: 99%
“…A gene dosage effect has been recorded for NBS patients too, with cancer occurrence lower in a subgroup of patients with above average p70-nibrin levels [117]. The individual variation in p70-nibrin levels is thought to reflect differences in its proteolytic turnover rather than differences in expression level [118]. …”
Section: Aetiopathogenesismentioning
confidence: 99%